NGeneBio
Business Services · South Korea · 51-200 Employees
View Company Info for Free
Overview
Headquarters
#303-307 904ho 288, Guro-gu, Seoul, Sout...Phone Number
+82 28679798Website
www.ngenebio.comRevenue
$5.4 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About NGeneBio
NGeneBio Co., Ltd. is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was founded in October 2015, headquartered in Seoul, South Korea as a joint venture between Genecurix and Korea Telecom. The company launched NGS-based hereditary breast/ovarian cancer panel (BRCAaccuTestTM) with clinical analysis SW (NGeneAnalysisTM) in 2016. BRCA NGS panel for PARP inhibitor CDx test and solid tumor/hematologic cancer NGS panels will be launched, inclusive of clinical data analysis SW platform. The mission of the company is to provide clinically validated NGS based IVD/CDx products/services with convergence of innovative bioinformatics and SW development capacity for global market.Explore more
NGeneBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NGeneBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if NGeneBio is spiking on competitors!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if NGeneBio has recently received funding, and reach out quickly before it becomes old news!
NGeneBio, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at NGeneBio
Click to see if NGeneBio had a recent Job posting/layoffs
Funding: Get notified immidiatlly once NGeneBio has new funding data
Product Launch: Get notified when NGeneBio launches new products
Earning: See what the market has to say on NGeneBio recently announced quarterly report
Recommended Actions
Find VP level buyers at NGeneBio
Find 3 more new buyers
Company Profile Activity
Activity Insights
NGeneBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NGeneBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NGeneBio.
NGeneBio financials insights
Gather financial insights about NGeneBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Stock Offering
$32M
NGeneBio Tech Stack
A closer look at the technologies used by NGeneBio
NGeneBio News & Media
MGI Partners with NGeneBio to Advance Precision Medicine
SEOUL, South Korea, Aug. 23, 2023 /PRNewswire/ -- MGI, a company committed to building core tools and technology to lead life science and NGeneBio, a company specializing in next-generation sequencing-based diagnostic have signed a memorandum of understanding (MOU) to expand the commercial access of NGeneBio's cancer testing products globally. This strategic partnership will enable the integration of NGeneBio's advanced diagnostic assays with MGI's high-throughput sequencing technology to acceleNgeneBio Partners With MGI Tech on Precision Cancer Diagnostics - 360Dx
The South Korean NGS diagnostic firm will combine its cancer diagnostic tests with MGI’s DNBSeq-G99 sequencer to expand its global commercial presence.Following IPO, Korean Diagnostics Firm NGeneBio Sets Sights on International Markets
NEW YORK – After having recently raised $32 million via an initial public offering in its home country, Korean molecular diagnostics provider NGeneBio intends to invest in human resources, R&D, and expanding to international markets, with the US a particular target. "Our immediate goal is…
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding NGeneBio
Sign Up For FreeTo access detailed company insights
NGeneBio Co., Ltd. is a leading company in molecular diagnostics (MDx) and companion diagnostics (CDx), which develops and provides next generation sequencing (NGS)-based in vitro diagnostics (IVD) panel and clinical analysis software (SW). NGeneBio was founded in October 2015, headquartered in Seoul, South Korea as a joint venture between Genecuri... Read More
